Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x100px

Organisation › Details

JLABS @ BE (Beerse)

https://jlabs.jnjinnovation.com/locations/jlabs-be

	Start	2018-10-22 existent
	Group	Johnson & Johnson (JnJ) (Group)
	Industry	business park management / science park management
	Industry 2	LIFE SCIENCES

	Region	Beerse
	Country	Belgium
	Street	30 Turnhoutseweg Building B019
	City	2340 Beerse
	Tel	+32-14-621500
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2024-02-12

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Johnson & Johnson (JnJ) (Group)

[1] Johnson & Johnson Inc.. (1/13/25). "Press Release: Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.". New Brunswick, NJ & Bedminster, NJ....
[2] Addex Therapeutics S.A.. (7/22/24). "Press Release: Addex’s Partner Discontinues ADX71149 Development in Epilepsy". Geneva....
[3] Bright Peak Therapeutics AG. (6/11/24). "Press Release: Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials". Basel & San Diego, CA....
[4] Numab Therapeutics AG. (5/28/24). "Press Release: Numab Therapeutics Announces Johnson & Johnson to Acquire Its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis". H...
[5] Addex Therapeutics S.A.. (4/29/24). "Press Release: Addex Provides Update on ADX71149 Phase 2 Epilepsy Study". Geneva....
[6] Basel Area Business & Innovation. (4/26/24). "Press Release: Johnson & Johnson Opens Innovation Hub in Allschwil"....
[7] Recursion Pharmaceuticals, Inc.. (4/16/24). "Press Release: Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer". Salt Lake City, UT....
[8] Asgard Therapeutics AB. (3/14/24). "Press Release: Asgard Therapeutics Announces €30 Million Series A Financing to Advance Its First-in-Class in vivo Cell Reprogramming Platform for Immuno-oncology". Lund....
[9] Johnson & Johnson. (1/8/24). "Press Release: Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer". New Brunswick, NJ....
[10] LegoChem Biosciences, Inc.. (12/26/23). "Press Release: LegoChem Biosciences Announces License Agreement for LCB84 Trop2-Targeted ADC". Daejeon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]